Differential impact of oleate, palmitate, and adipokines on expression of NF-κB target genes in human vascular smooth muscle cells

Molecular and Cellular Endocrinology

Volumn 362, Issue 1-2, 2012, Pages 194-201

  Lamers, Daniela ^a   Schlich, Raphaela ^a   Horrighs, Angelika ^a   Cramer, Andrea ^a   Sell, Henrike ^a   Eckel, Juergen ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Inflammation; NF B; Oleic acid; Palmitic acid; Vascular dysfunction; Vascular smooth muscle cells

Indexed keywords

ACTIVIN A; ADIPOCYTOKINE; ANGIOPOIETIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; OLEIC ACID; PALMITIC ACID;

ADIPOCYTE; ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC REGULATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE CELL;

ACTIVINS; ADIPOCYTES; ADIPOKINES; ANGIOPOIETINS; APOPTOSIS REGULATORY PROTEINS; ATHEROSCLEROSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL5; CULTURE MEDIA, CONDITIONED; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; OBESITY; OLEIC ACID; PALMITIC ACID; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 84865291496     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.06.010     Document Type: Article

References (43)

1. Baker R.G., Hayden M.S., Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011, 13:11-22.
2. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96:939-949.
3. Brasier A.R. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc. Res. 2010, 86:211-218.
4. Correia M.L., Haynes W.G. Leptin, obesity and cardiovascular disease. Curr. Opin. Nephrol. Hypertens. 2004, 13:215-223.
5. Deinum J., Chaturvedi N. The renin-angiotensin system and vascular disease in diabetes. Semin. Vasc. Med. 2002, 2:149-156.
6. Dietze-Schroeder D., Sell H., Uhlig M., Koenen M., Eckel J. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 2005, 54:2003-2011.
7. Engelse M.A., Neele J.M., van Achterberg T.A., van Aken B.E., van Schaik R.H., Pannekoek H., de Vries C.J. Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells. Circ. Res. 1999, 85:931-939.
8. Gamble J.R., Drew J., Trezise L., Underwood A., Parsons M., Kasminkas L., Rudge J., Yancopoulos G., Vadas M.A. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ. Res. 2000, 87:603-607.
9. Hauner H., Petruschke T., Russ M., Rohrig K., Eckel J. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 1995, 38:764-771.
10. Hu F.B., Willett W.C., Li T., Stampfer M.J., Colditz G.A., Manson J.E. Adiposity as compared with physical activity in predicting mortality among women. N. Engl. J. Med. 2004, 351:2694-2703.
11. Iacobellis G., Gao Y.J., Sharma A.M. Do cardiac and perivascular adipose tissue play a role in atherosclerosis?. Curr. Diab. Rep. 2008, 8:20-24.
12. Ishikado A., Nishio Y., Yamane K., Mukose A., Morino K., Murakami Y., Sekine O., Makino T., Maegawa H., Kashiwagi A. Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells. Atherosclerosis 2009, 205:404-412.
13. Jeon B.H., Khanday F., Deshpande S., Haile A., Ozaki M., Irani K. Tie-ing the antiinflammatory effect of angiopoietin-1 to inhibition of NF-kappaB. Circ. Res. 2003, 92:586-588.
14. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., Kannel W.B., Vasan R.S. Obesity and the risk of heart failure. N. Engl. J. Med. 2002, 347:305-313.
15. Kojima I., Mogami H., Kawamura N., Yasuda H., Shibata H. Modulation of growth of vascular smooth muscle cells by activin A. Exp. Cell Res. 1993, 206:152-156.
16. Kozaki K., Akishita M., Eto M., Yoshizumi M., Toba K., Inoue S., Ishikawa M., Hashimoto M., Kodama T., Yamada N., Orimo H., Ouchi Y. Role of activin-A and follistatin in foam cell formation of THP-1 macrophages. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2389-2394.
17. Krohn R., Raffetseder U., Bot I., Zernecke A., Shagdarsuren E., Liehn E.A., van Santbrink P.J., Nelson P.J., Biessen E.A., Mertens P.R., Weber C. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 2007, 116:1812-1820.
18. Lakka H.M., Lakka T.A., Tuomilehto J., Salonen J.T. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur. Heart J. 2002, 23:706-713.
19. Lamers D., Schlich R., Greulich S., Sasson S., Sell H., Eckel J. Oleic acid and adipokines synergize in inducing proliferation and inflammatory signaling in human vascular smooth muscle cells. J. Cell Mol. Med. 2011, 15:1177-1188.
20. Li M., Fukagawa N.K. Age-related changes in redox signaling and VSMC function. Antioxid. Redox Signal. 2010, 12:641-655.
21. Mahabadi A.A., Reinsch N., Lehmann N., Altenbernd J., Kalsch H., Seibel R.M., Erbel R., Mohlenkamp S. Association of pericoronary fat volume with atherosclerotic plaque burden in the underlying coronary artery: a segment analysis. Atherosclerosis 2010, 211:195-199.
22. Maloney E., Sweet I.R., Hockenbery D.M., Pham M., Rizzo N.O., Tateya S., Handa P., Schwartz M.W., Kim F. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1370-1375.
23. McCarthy S.A., Bicknell R. Inhibition of vascular endothelial cell growth by activin-A. J. Biol. Chem. 1993, 268:23066-23071.
24. Molloy C.J., Taylor D.S., Pawlowski J.E. Novel cardiovascular actions of the activins. J. Endocrinol. 1999, 161:179-185.
25. Nakaoka T., Gonda K., Ogita T., Otawara-Hamamoto Y., Okabe F., Kira Y., Harii K., Miyazono K., Takuwa Y., Fujita T. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J. Clin. Invest. 1997, 100:2824-2832.
26. Nordstrom E.A., Ryden M., Backlund E.C., Dahlman I., Kaaman M., Blomqvist L., Cannon B., Nedergaard J., Arner P. A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity. Diabetes 2005, 54:1726-1734.
27. Nykanen A.I., Krebs R., Saaristo A., Turunen P., Alitalo K., Yla-Herttuala S., Koskinen P.K., Lemstrom K.B. Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 2003, 107:1308-1314.
28. Oberbach A., Schlichting N., Bluher M., Kovacs P., Till H., Stolzenburg J.U., Neuhaus J. Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections. PLoS One 2010, 5:e10882.
29. Pawlowski J.E., Taylor D.S., Valentine M., Hail M.E., Ferrer P., Kowala M.C., Molloy C.J. Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. J. Clin. Invest. 1997, 100:639-648.
30. Puri V., Ranjit S., Konda S., Nicoloro S.M., Straubhaar J., Chawla A., Chouinard M., Lin C., Burkart A., Corvera S., Perugini R.A., Czech M.P. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc. Nat. Acad. Sci. U.S.A. 2008, 105:7833-7838.
31. Ruan H., Lodish H.F. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 2003, 14:447-455.
32. Schober A., Manka D., von Hundelshausen P., Huo Y., Hanrath P., Sarembock I.J., Ley K., Weber C. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 2002, 106:1523-1529.
33. Sell H., Eckardt K., Taube A., Tews D., Gurgui M., Echten-Deckert G., Eckel J. Skeletal muscle insulin resistance induced by adipocyte-conditioned medium: underlying mechanisms and reversibility. Am. J. Physiol Endocrinol. Metab. 2008, 294:E1070-E1077.
34. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., Yancopoulos G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 2000, 6:460-463.
35. van Dam R.M., Willett W.C., Manson J.E., Hu F.B. The relationship between overweight in adolescence and premature death in women. Ann. Intern. Med. 2006, 145:91-97.
36. Wichelhaus A., Russ M., Petersen S., Eckel J. G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from STZ-diabetic rats. Am. J. Physiol. 1994, 267:H548-H555.
37. Yamada R., Suzuki T., Hashimoto M., Eto Y., Shiokawa K., Muramatsu M. Induction of differentiation of the human promyelocytic cell line HL-60 by activin/EDF. Biochem. Biophys. Res. Commun. 1992, 187:79-85.
38. Yeop H.C., Kargi A.Y., Omer M., Chan C.K., Wabitsch M., O'Brien K.D., Wight T.N., Chait A. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 2010, 59:386-396.
39. Dyntar D., Eppenberger-Eberhardt M., Maedler K., Pruschy M., Eppenberger H.M., Spinas G.A., Donath M.Y. Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes 2001, 50:2105-2113.
40. Listenberger L.L., Ory D.S., Schaffer J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 2001, 276:14890-14895.
41. Mattern H.M., Hardin C.D. Vascular metabolic dysfunction and lipotoxicity. Physiol. Res. 2007, 56:149-158.
42. Staiger H., Staiger K., Stefan N., Wahl H.G., Machicao F., Kellerer M., Häring H.U. Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 2004, 53:3209-3216.
43. Yuzefovych L., Wilson G., Rachek L. Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E1096-1105.